Opsoclonus-myoclonus syndrome associated with cytomegalovirus encephalitis.
Zaganas
I
I
Neurology Department, University Hospital of Heraklion, Voutes, Crete, Greece.
Prinianakis
G
G
Xirouchaki
N
N
Mavridis
M
M
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology / Q000503:physiopathology; D003586:Cytomegalovirus Infections / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D018792:Encephalitis, Viral / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D007136:Immunoglobulins / Q000097:blood / Q000276:immunology / Q000627:therapeutic use; D008297:Male; D053578:Opsoclonus-Myoclonus Syndrome / Q000276:immunology* / Q000503:physiopathology / Q000821:virology*; D013256:Steroids / Q000627:therapeutic use; D016896:Treatment Outcome
D000998:Antiviral Agents; D007136:Immunoglobulins; D013256:Steroids